A Social Security processing error is causing serious financial concerns for 250,000 Medicare beneficiaries, and more news to know this week.
When the USP <800> takes effect on December 1, retail and LTC pharmacies carrying hazardous drugs will be expected to comply. Follow these three steps to get started on the right path.
As the push to minimize tobacco use continues, pharmacists are seeing an increasing number of opportunities to help smokers looking to kick the habit.
Nearly 1,000 measles cases have been reported, rising healthcare costs are a top financial issue for Americans, the first major opioid trial is underway, and more news to know.
In this Q&A, T.W. Taylor, Pharm.D., owner of Williamsburg Drug Co., shares his successes with CBD at his pharmacy, how he addresses patient concerns, and advice for pharmacies looking to break into the CBD market.
A new study says CBD is effective in treating opioid addiction, CMS takes aim at PBM spread pricing in new guidance, patients aren’t completely sold on virtual health, and more.
Seemingly out of nowhere, the CBD market has skyrocketed in the past five years to a level that demands attention. Its push to enter the mainstream gained significant momentum last December when the 2018 Agriculture Improvement Act (also known as the Farm Bill) made hemp-derived CBD legal to sell and consume nationwide. With the public’s …
Pharmacy groups respond to a final drug pricing rule without DIR reform, why patients decline statins, rural organizations get $240 million to fight opioid use, and more.
CMS finalizes a rule to include list prices in TV drug ads, Medicare Advantage beneficiaries could save millions thanks to pending telehealth rules, and more news to know.
The value of OTCs to healthcare, the rise of specialty drug spending in Medicare Part D, CMS to test integrated care models for dual eligible beneficiaries, and more industry news to know.